Oral Pathology Discipline, Dentistry Department, State University of Maringa, Av. Mandacaru, 1550, CEP 87080-000, Maringa, PR, Brazil.
Oral Oncology Center, São Paulo State University (UNESP), School of Dentistry, Rua José Bonifácio, 1193, CEP 16015-050, Araçatuba, SP, Brazil.
Pathol Res Pract. 2019 Jul;215(7):152450. doi: 10.1016/j.prp.2019.152450. Epub 2019 May 13.
Differential diagnosis among fibrous dysplasias, cemento-ossifying fibromas and cemento-osseous dysplasias is difficult, since there is considerable overlap of histologic features, but also extremely important, since they differ greatly in etiology, clinical behaviour, prognosis and terapeuthic approach. There is no data about the use of immunohistochemistry, a viable and accessible technique, for this purpose. The objective of this study was to investigate, comparatively, the immunohistochemical expression of major non-collagenous proteins (osteonectin [ON], osteopontin [OP], bone sialoprotein [BSP] and osteocalcin [OC]) of mineralized tissue extracellular matrix in 22 cases of fibrous dysplasias, 16 of cemento-ossifying fibromas and 16 of cemento-osseous dysplasias. ON maintained the same expression profile in all cases; the staining for OP was negative in fusiform cells producing cementoid globules and weak, as well as heterogeneous, in high mineralized matrixes; there was negativity for BSP in cementoid globules and in the fusiform cells that produce them, differently from the strong positive expression found in the majority of bone trabeculae and their peripheral cuboidal osteoblasts; and finally, the immuno-reactivity for OC was weak, except in cuboidal osteoblasts and osteocytes. We can conclude that the nature of mineralized structure and the cellular phenotype are much more responsible for variability in immunohistochemical profile than the type of lesion (fibrous dysplasias, cemento-ossifying fibromas and cemento-osseous dysplasias) which makes difficult, at least for a while, the use of these proteins with diagnosis purpose.
纤维结构不良、骨化性纤维瘤和骨化性纤维发育不良之间的鉴别诊断较为困难,因为其组织学特征有很大的重叠,但也非常重要,因为它们在病因、临床行为、预后和治疗方法上有很大的不同。目前还没有关于使用免疫组织化学(一种可行且易于获得的技术)来进行诊断的相关数据。本研究的目的是比较研究 22 例纤维结构不良、16 例骨化性纤维瘤和 16 例骨化性纤维发育不良中矿化组织细胞外基质主要非胶原蛋白(骨粘连蛋白[ON]、骨桥蛋白[OP]、骨唾液蛋白[BSP]和骨钙素[OC])的免疫组织化学表达。ON 在所有病例中保持相同的表达模式;成骨细胞产生的水泥样小球和高矿化基质中的 OP 染色呈阴性,且染色不均匀;BSP 在水泥样小球和成骨细胞中呈阴性,而在大多数骨小梁及其周围的立方状成骨细胞中呈强阳性表达;OC 的免疫反应性较弱,除了在立方状成骨细胞和骨细胞中。我们可以得出结论,矿化结构的性质和细胞表型比病变类型(纤维结构不良、骨化性纤维瘤和骨化性纤维发育不良)更能决定免疫组织化学谱的变异性,这使得至少在一段时间内,这些蛋白的诊断用途变得困难。